Wills A, Taylor E, Pantosti A, Phillips I, Tabaqchali S
J Clin Pathol. 1982 Mar;35(3):304-8. doi: 10.1136/jcp.35.3.304.
Twenty-two known strains of the Bacteroides fragilis group of organisms and 67 clinical specimens from a variety of sites were examined by fluorescent antibody test (IFA) using two different antisera fro the rapid detection of B fragilis group of organisms. A previously reported Barts' pooled antisera was compared with a commercially produced Fluoretec kit antisera and the findings were related to routine anaerobic culture and gas liquid chromatography for short chain fatty acids. The Barts' antisera was more sensitive (88%) but less specific (88%) than the kit (sensitivity 50%, specificity 98%). This indicates that Barts' antisera picks up more positive cultures than the kit. The predictive value of a positive test was 82% for Barts' antisera and 93% for the kit. There were higher numbers of false-negatives with the kit (13/26) than with the Barts' (3/26). The predictive value of a negative test was 92% for Barts' antisera and 75% for the kit, indicating that a negative IFA test with Barts' antisera is a reliable index of the absence of the B fragilis group of organisms from clinical specimens. The implications for the use of this test in a routine laboratory are discussed.
使用两种不同抗血清,通过荧光抗体试验(IFA)对22种已知的脆弱拟杆菌属生物体菌株以及来自不同部位的67份临床标本进行检测,以快速检测脆弱拟杆菌属生物体。将先前报道的巴茨混合抗血清与市售的Fluoretec试剂盒抗血清进行比较,结果与常规厌氧培养和短链脂肪酸的气液色谱分析相关。巴茨抗血清比试剂盒更敏感(88%)但特异性更低(88%)(试剂盒敏感性50%,特异性98%)。这表明巴茨抗血清比试剂盒检测到更多阳性培养物。巴茨抗血清阳性检测的预测值为82%,试剂盒为93%。试剂盒的假阴性数量(13/26)高于巴茨抗血清(3/26)。巴茨抗血清阴性检测的预测值为92%,试剂盒为75%,这表明巴茨抗血清IFA检测阴性是临床标本中不存在脆弱拟杆菌属生物体的可靠指标。讨论了该检测方法在常规实验室中的应用意义。